B-cell acute lymphoblastic leukemia/lymphoma in relapse presenting as a cervical mass: A case report and review of literature

Jamil Kazma(American University of Beirut Medical Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Ken H. Young(Duke Medical Center), Nitin Jain(Parul University), Vasantha Lakshmi Gali(The University of Texas MD Anderson Cancer Center), Cynae Johnson(The University of Texas MD Anderson Cancer Center)
Gynecologic Oncology Reports
August 1, 2019
10.1016/j.gore.2019.08.003
Cited by 4

Related Papers

Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
|Journal of Clinical Oncology|2012|682
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508
Ibrutinib and Venetoclax for First-Line Treatment of CLL
|New England Journal of Medicine|2019|502